After Hours Decliner
RYTM Rhythm Pharmaceuticals90.51+3.13+3.6%
After Hours:86.00-4.51 (-5.0%)
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Globe NewswireMon, 16-Mar 4:01 PM
After Hours Decliner
RYTM Rhythm Pharmaceuticals90.51+3.13+3.6%
After Hours:86.00-4.51 (-5.0%)
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Globe NewswireMon, 16-Mar 4:01 PM
RYTM Rhythm Pharmaceuticals100.79+0.10 (+0.1%)
RYTM Rhythm Pharmaceuticals96.29-0.19 (-0.2%)